Pasar al contenido principal

MAP3K8 Y HORMONAS TIROIDEAS NUEVAS DIANAS EN LA MALARIA EXPERIMENTAL

SAF2017-83289-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2017
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Abnormal dendritic cell-poiesis in patients with lower-risk myelodysplastic syndromes

  • Sánchez, Ángela
  • Anguita, Eduardo
  • Chaparro, Alberto
  • Etcheverry, Roldán
  • José, Juan
  • López-García, Alberto
  • Ramos-Acosta, Carlos
  • Oancea, Raluca
  • Rodriguez-Muñoz, Diego
  • Alemany, Susana
© 2020 the Author(s)., Myelodysplastic syndromes (MDS) are clonal hematopoietic stem/progenitor cell disorders associated with ineffective hematopoiesis and peripheral blood cytopenia(s). Mounting evidence suggests that immune system regulation plays an important role in MDS pathogenesis and progression.1 The Revised International Prognostic Scoring System (IPSS-R) divided MDS patients in four risk groups,2 in which, for simplicity's sake, very low, low, and intermediate risk groups can be united into one lower-risk MDS group, as higher-risk MDSs are closer to acute myeloid leukemia., This work was supported by SAF2014-52009-R (SA) and SAF2017-83289-R (SA) from the Spanish Ministry of Economy and Competitiveness and by the European Regional Development Funds (FEDER), B2017/BMD-3724 (SA) from the Comunidad de Madrid and Hay Esperanza Foundation (EA).